Arab Pharmaceuticals

مادة اعلانية

Latest Update: 10 June 2025 15:10 Abu Dhabi Time.

Market Status: Closed

ADCI

Arab Pharmaceuticals

172.20

EGP

-0.970

-0.56%

Open

173.17

Prev Close

173.17

PX_VOLUME

380

MARKET CAP (M)

DAY RANGE

171.28 - 175.45

52 WEEKS

76.02 - 186.50

Stock Statistics

Yearly Change

115.39%

Listed Shares (Million)

6.00

Earnings Multiple

5.62

Average 30-day trading volume

2,773.12

Price-to-book ratio

1.85

Earnings Per Share

17.14

Previous Dividend Distribution

7.93

Dividend Yield

4.82%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		263.29	324.80	233.33	204.44	167.19	222.66	191.24
Gross Profit		109.95	142.60	94.63	68.62	44.23	87.45	65.69
Operating Income		84.45	95.80	48.16	23.44	10.37	45.64	33.77
Profit Margin		22.28	21.46	15.56	9.94	10.06	17.19	14.34

	Period Ending:	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Revenue		785.52	633.73	505.04	537.05
Gross Profit		265.99	224.35	185.43	230.30
Operating Income		118.10	94.76	89.82	122.16
Profit Margin		13.09	13.06	15.11	18.88

Balance Sheet

	Period Ending:	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		1,266.46	1,215.16	1,198.23	1,133.59	1,100.14	1,057.19	732.60
Total Liabilities		706.28	713.65	766.75	675.06	657.93	645.23	321.95
Total Equity		560.18	501.51	431.48	458.53	442.21	411.96	410.65

Cash Flows Statements - Coming Soon

* In Million of Egypt Pound

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.